Journal
MOLECULES
Volume 22, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/molecules22061014
Keywords
resveratrol; cancer; signal transduction; p53; clinical trials
Funding
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq awards)
- Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
- Fundacao do Cancer
- Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Instituto Nacional de Ciencia e Tecnologia - INCT Program)
Ask authors/readers for more resources
Increasing epidemiological and experimental evidence has demonstrated an inverse relationship between the consumption of plant foods and the incidence of chronic diseases, including cancer. Microcomponents that are naturally present in such foods, especially polyphenols, are responsible for the benefits to human health. Resveratrol is a diet-derived cancer chemopreventive agent with high therapeutic potential, as demonstrated by different authors. The aim of this review is to collect and present recent evidence from the literature regarding resveratrol and its effects on cancer prevention, molecular signaling (especially regarding the involvement of p53 protein), and therapeutic perspectives with an emphasis on clinical trial results to date.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available